Evidence map›Paper›PMID 30126135›Full record

ReviewPharmaceutics2018

Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals.

Fakhrossadat Emami, Alireza Vatanara, Eun Ji Park, Dong Hee Na

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Scalable production of pectinases fromFood science and biotechnology · 2026
    Article
  3. Review
  4. Article
  5. Optimization ofMolecules (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Review
  12. Article
  13. Article
  14. Trends in uptake and impact of thermostable vaccines in Africa.Therapeutic advances in vaccines and immunotherapy · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fakhrossadat EmamiCollege of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614411, Iran. f-emami@razi.tums.ac.ir.
Alireza VatanaraCollege of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614411, Iran. vatanara@tums.ac.ir.
Eun Ji ParkCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea. 1978ej@naver.com.
Dong Hee NaCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea. dhna@cau.ac.kr.ORCID 0000-0001-9313-0127

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solid dosage forms of biopharmaceuticals such as therapeutic proteins could provide enhanced bioavailability, improved storage stability, as well as expanded alternatives to parenteral administration. Although numerous drying methods have been used for preparing dried protein powders, choosing a suitable drying technique remains a challenge. In this review, the most frequent drying methods, such as freeze drying, spray drying, spray freeze drying, and supercritical fluid drying, for improving the stability and bioavailability of therapeutic proteins, are discussed. These technologies can prepare protein formulations for different applications as they produce particles with different sizes and morphologies. Proper drying methods are chosen, and the critical process parameters are optimized based on the proposed route of drug administration and the required pharmacokinetics. In an optimized drying procedure, the screening of formulations according to their protein properties is performed to prepare a stable protein formulation for various delivery systems, including pulmonary, nasal, and sustained-release applications.

Indexed as

bioavailabilitybiopharmaceuticalsdrying technologypharmacokineticsprotein stability

Identifiers

PMID30126135
PMCPMC6161129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.